A long life catalyst is provided that is conveniently and inexpensively capable of being produced and that is highly active and has inhibited metal leakage. According to aspects of the present invention, a catalyst is provided that includes: a polymer including a plurality of first structural units and a plurality of second structural units; and metal acting as a catalytic center, wherein at least part of the metal is covered with the polymer, each of the plurality of first structural units has a first atom constituting a main chain of the polymer and a first substituent group bonded to the first atom, a second atom included in each of the plurality of second structural units is bonded to the first atom, and the second atom is different from the first atom, or at least one of all substituent groups on the second atom is different from the first substituent group.

A long life catalyst is provided that is conveniently and inexpensively capable of being produced and that is highly active and has inhibited metal leakage. According to aspects of the present invention, a catalyst is provided that includes: a polymer including a plurality of first structural units and a plurality of second structural units; and metal acting as a catalytic center, wherein at least part of the metal is covered with the polymer, each of the plurality of first structural units has a first atom constituting a main chain of the polymer and a first substituent group bonded to the first atom, a second atom included in each of the plurality of second structural units is bonded to the first atom, and the second atom is different from the first atom, or at least one of all substituent groups on the second atom is different from the first substituent group.

A system and method for reducing carbon dioxide in an electrochemical cell comprising a first cell compartment, a second cell compartment, and a membrane positioned between the first cell compartment and the second cell compartment is disclosed. The method may include introducing a feed containing a carbon dioxide gas and a feed of catholyte at a cathode positioned in the first cell compartment, in which the cathode contains a gas diffusion electrode comprising a carbon cloth or graphitized carbon weave and wherein the carbon dioxide gas is directed through carbon fibers of the carbon cloth or graphitized carbon weave. The method may further include introducing a feed of anolyte at an anode positioned in the second cell compartment and applying an electrical potential between the anode and the cathode of the electrochemical cell to thereby reduce the carbon dioxide to a reduction product.

A carbonylation process in the presence of a pretreated zeolite catalyst which comprises the sequential steps (i) pretreating the catalyst and (ii) carbonylating dimethyl ether with a carbon monoxide-containing gas to produce methyl acetate in which the catalyst pretreatment step (i) comprises a step (a) contacting the catalyst with a first treatment mixture comprising water vapour; and a step (b) contacting the treated catalyst of step (a) with a second treatment mixture comprising an inert gas and at least one of dimethyl ether and methanol.

A carbonylation process in the presence of a pretreated zeolite catalyst which comprises the sequential steps (i) pretreating the catalyst and (ii) carbonylating dimethyl ether with a carbon monoxide-containing gas to produce methyl acetate in which the catalyst pretreatment step (i) comprises a step (a) contacting the catalyst with a first treatment mixture comprising water vapour; and a step (b) contacting the treated catalyst of step (a) with a second treatment mixture comprising an inert gas and at least one of dimethyl ether and methanol.

In one aspect, the invention relates methods for inhibiting or preventing muscle atrophy or increasing muscle mass by providing to a subject in need thereof an effective amount of ursolic acid, a derivative thereof, or an analog of the ursane scaffold. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

In one aspect, the invention relates methods for inhibiting or preventing muscle atrophy or increasing muscle mass by providing to a subject in need thereof an effective amount of ursolic acid, a derivative thereof, or an analog of the ursane scaffold. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The present invention relates to a group of derivatives synthesized based on the ent-kaurane diterpenoid flexicaulin A and the methods to synthesize such diterpenoid derivatives. In particular, the chemical entities of such synthetic diterpene compounds in the manufacture of a medicament is for the treatment of tumors or cancers.

A compound of Formula I or pharmaceutically acceptable salt thereof and its preparation method and applications, the new structure of the compound of formula I has not been reported in literature. It is isolated from Isodon forrestii var. forrestii and can be a compound served as Trx1 selective inhibitor. The present invention further discloses a pharmaceutical composition, preparation of the compound of Formula I and its applications in preparing medicines for preventing or treating cancer. Iso A of the present invention has the advantages of low toxicity, high safety and strong pharmacological effect, which suggests a potential prospect in pharmaceutical applications.

A compound of Formula I or pharmaceutically acceptable salt thereof and its preparation method and applications, the new structure of the compound of formula I has not been reported in literature. It is isolated from Isodon forrestii var. forrestii and can be a compound served as Trx1 selective inhibitor. The present invention further discloses a pharmaceutical composition, preparation of the compound of Formula I and its applications in preparing medicines for preventing or treating cancer. Iso A of the present invention has the advantages of low toxicity, high safety and strong pharmacological effect, which suggests a potential prospect in pharmaceutical applications.